Linoleic Acid (DB14104): A Comprehensive Monograph on its Biochemistry, Pharmacology, and Clinical Significance

Executive Summary

Linoleic acid (LA) is the primary essential omega-6 polyunsaturated fatty acid (PUFA) in the human diet, indispensable for specific physiological functions, most notably the maintenance of the epidermal water barrier. As an essential nutrient, it cannot be synthesized de novo by the human body and must be obtained from dietary sources. However, the biological role of linoleic acid is characterized by a profound paradox. While required in modest amounts (1-2% of daily caloric intake) to prevent deficiency, the unprecedented and excessive consumption characteristic of modern, industrialized diets has positioned it at the center of controversies regarding chronic inflammatory diseases, metabolic syndrome, and cardiovascular health.

The biological effect of linoleic acid is not absolute but is critically dependent on the broader metabolic context. Its ultimate physiological impact is governed by a complex interplay of factors, chief among them being the dietary ratio of omega-6 to omega-3 fatty acids. These two fatty acid families compete for the same enzymatic pathways to produce eicosanoids—potent, hormone-like signaling molecules. An excess of omega-6 substrates, typical of Western diets with ratios of 15:1 or higher, drives the synthesis of pro-inflammatory and pro-thrombotic mediators. Conversely, a balanced ratio, closer to the 1:1 to 4:1 range of ancestral human diets, promotes a state of inflammatory homeostasis. Therefore, the omega-6/omega-3 ratio functions as a critical metabolic switch, determining whether the downstream cascade of linoleic acid metabolism results in a balanced physiological state or a chronic, low-grade pro-inflammatory condition.

This report synthesizes the extensive body of evidence on linoleic acid, covering its fundamental physicochemical properties, complex metabolic fate, and multifaceted molecular mechanisms of action. It critically examines the conflicting clinical evidence, particularly surrounding cardiovascular disease, and proposes a unifying framework that considers the dietary source of linoleic acid—whether from whole foods or from highly refined industrial seed oils—as a key determinant of its health effects. The analysis concludes that a nuanced, context-aware perspective is essential, moving beyond a simplistic "good" versus "bad" dichotomy. The central public health challenge is not one of deficiency, but of managing a profound dietary excess and imbalance, necessitating a shift in focus from ensuring adequate intake to restoring a healthier omega-6 to omega-3 ratio.

Compound Identification and Physicochemical Properties

A precise and unambiguous identification of a chemical entity is the foundation of rigorous pharmacological and biochemical analysis. Linoleic acid, due to its ubiquity across food science, metabolomics, clinical medicine, and industrial chemistry, is known by a multitude of names and is cataloged in numerous databases.

Nomenclature and Identifiers

The standard nomenclature for this compound is linoleic acid.[1] Its systematic name under the International Union of Pure and Applied Chemistry (IUPAC) guidelines is (9Z,12Z)-octadeca-9,12-dienoic acid.[1] This name precisely describes its structure as an 18-carbon fatty acid with two double bonds at the 9th and 12th carbon atoms, both in the

cis (or Z for zusammen) configuration.

Alternative systematic names and common synonyms are frequently encountered in scientific literature and commercial products. These include cis,cis-9,12-Octadecadienoic acid, Linolic acid, and Telfairic acid.[1] The sheer number of identifiers across various domains underscores its fundamental importance. It is cataloged in major chemical and biological databases, ensuring its unique identification for research, regulatory, and clinical purposes. A consolidated list of these identifiers is provided in Table 2.1.

Table 2.1: Comprehensive Identifiers for Linoleic Acid

Identifier Type	Value	Source(s)
Primary Name	Linoleic acid	1
IUPAC Name	(9Z,12Z)-octadeca-9,12-dienoic acid	1
DrugBank ID	DB14104	1
CAS Number	60-33-3	1
PubChem CID	5280450	1
ChEBI ID	CHEBI:17351	1
SMILES	CCCCC/C=C\C/C=C\CCCCCCCC(=O)O	1
InChIKey	OYHQOLUKZRVURQ-HZJYTTRNSA-N	1
Molecular Formula	C18​H32​O2​	1
FDA UNII	9KJL21T0QJ	1
HMDB ID	HMDB0000673	1
KEGG ID	C01595	1
RxCUI	6400	1
FEMA Number	3380	1
EC Number	200-470-9	1

Chemical Structure and Molecular Formula

Linoleic acid is an organic compound with the molecular formula C18​H32​O2​.[1] Its structure is characterized by an 18-carbon aliphatic chain terminating in a carboxylic acid functional group (

−COOH).[3] The defining feature of its structure is the presence of two double bonds located between carbons 9-10 and 12-13 (counting from the carboxyl carbon). Both of these double bonds possess a

cis stereochemistry.[1]

This cis configuration forces a bend or "kink" in the hydrocarbon chain at each double bond.[3] This structural feature is of immense biological importance. Unlike saturated fatty acids, which have straight chains and can pack tightly together, the kinks in linoleic acid prevent close packing. When incorporated into cell membranes as part of phospholipids, this property increases the fluidity and flexibility of the membrane, which is crucial for proper cell function, signaling, and nutrient transport.[3] As an omega-6 fatty acid, the final double bond is located six carbons from the methyl (omega) end of the molecule.[4] Computational representations, including InChI, InChIKey, and SMILES strings, are available to facilitate unambiguous database searching and structural analysis.[1] Three-dimensional structural data have also been generated.[11]

Physical and Chemical Properties

The physicochemical properties of linoleic acid govern its behavior in biological systems, its stability in food products, and its requirements for laboratory handling.

• Molecular Weight: The calculated molar mass is approximately 280.45 g/mol.[1]
• Appearance: At room temperature, linoleic acid is a colorless to pale yellow or straw-colored oily liquid.[1]
• Solubility: It is virtually insoluble in water but is soluble in many organic solvents such as acetone and is miscible with dimethylformamide.[8] This lipophilic nature dictates its transport in the body within lipoproteins and its partitioning into cellular membranes and adipose tissue.
• Thermal Properties: Linoleic acid has a melting point in the range of -5 °C to -12 °C and a boiling point of approximately 229-230 °C at a reduced pressure of 16 mmHg.[8]
• Stability and Reactivity: Linoleic acid is sensitive to air, light, and heat.[12] The hydrogen atoms on the carbon atom situated between the two double bonds (the bis-allylic position) are particularly susceptible to abstraction, initiating a free-radical chain reaction. This leads to oxidation, a process known as autoxidation.[8] This chemical instability is not merely a technical detail for storage; it is central to both its industrial utility and its biological activity. Industrially, this propensity to oxidize and crosslink upon exposure to air is exploited in the formulation of quick-drying oils, paints, and varnishes.[8] Biologically, this same chemical reactivity is the basis for the formation of oxidized linoleic acid metabolites (OXLAMs), which are increasingly implicated in the pathophysiology of chronic diseases when linoleic acid is consumed in excess.[15]

Biochemical Profile and Metabolism (Pharmacokinetics)

The journey of linoleic acid from dietary intake to its ultimate metabolic fate is a complex process that determines its concentration in tissues and its availability for conversion into a vast array of biologically active molecules.

Absorption, Distribution, and Elimination

Following consumption, dietary linoleic acid, typically in the form of triglycerides, is hydrolyzed in the small intestine and absorbed by enterocytes. Inside these cells, it is re-esterified and packaged into large lipoprotein particles called chylomicrons, primarily as triglycerides, phospholipids, or cholesterol esters.[17] These chylomicrons are then secreted into the lymphatic system and enter the general circulation via the thoracic duct.[17]

In the bloodstream, lipoprotein lipase acts on the chylomicrons, releasing fatty acids for uptake by peripheral tissues, such as muscle and adipose tissue. The chylomicron remnants are eventually cleared by the liver.[17] Once taken up by cells, the fate of linoleic acid is determined by the metabolic needs of the specific tissue. It can be utilized for energy production through β-oxidation, esterified for storage as triglycerides in adipose tissue, or incorporated into cellular membranes as phospholipids, where it plays a critical structural role by influencing membrane fluidity.[3]

A crucial pharmacokinetic parameter of linoleic acid is its exceptionally long biological half-life. Once incorporated into adipose tissue, its half-life is estimated to be approximately two years.[15] This has profound implications for human health and dietary interventions. It means that the composition of an individual's fat stores represents a long-term record of their dietary fat intake. Consequently, the metabolic effects of a high-linoleic acid diet can persist for years even after dietary changes are made, as the stored linoleic acid is slowly released back into circulation. This long-term storage and slow turnover make prevention of excessive intake critically important and suggest that clinical trials aiming to see benefits from reducing linoleic acid intake may need to be of very long duration to overcome this metabolic inertia.

The Linoleic Acid Metabolic Pathway

Linoleic acid is the parent compound of the omega-6 fatty acid family. Its primary metabolic function is to serve as a precursor for the synthesis of the 20-carbon PUFA, arachidonic acid (AA), through a series of desaturation and elongation steps that occur primarily in the endoplasmic reticulum.[8]

1. Desaturation: The first and rate-limiting step in this cascade is the introduction of a third double bond by the enzyme delta-6-desaturase (encoded by the FADS2 gene). This converts linoleic acid (18:2n-6) into gamma-linolenic acid (GLA; 18:3n-6).[18]
2. Elongation: GLA is then elongated by two carbons to form dihomo-gamma-linolenic acid (DGLA; 20:3n-6).[18]
3. Desaturation: Finally, the enzyme delta-5-desaturase (encoded by the FADS1 gene) introduces a fourth double bond, converting DGLA into arachidonic acid (AA; 20:4n-6).[18]

The rate-limiting nature of the initial delta-6-desaturase step creates a metabolic bottleneck. Under conditions of high dietary linoleic acid intake, this enzyme becomes saturated. As a result, increasing the substrate (linoleic acid) does not lead to a proportional increase in the final product (arachidonic acid). Instead, this bottleneck causes a "backup" of linoleic acid within the body's tissues. This excess substrate is then shunted into alternative metabolic pathways, providing a direct biochemical link between excessive intake and the production of other, potentially pathological, metabolites.

Oxidative Metabolism and Metabolite Formation

Beyond the canonical pathway to arachidonic acid, linoleic acid can be directly metabolized through oxidative pathways, generating a host of signaling molecules.

• Enzymatic Oxidation: Enzymes such as lipoxygenases (LOX), cyclooxygenases (COX), and cytochrome P450 (CYP) monooxygenases can act directly on linoleic acid.[8] These reactions produce a variety of oxidized metabolites, including mono-hydroxyl products like 9-hydroxy-octadecadienoic acid (9-HODE) and 13-hydroxy-octadecadienoic acid (13-HODE), as well as epoxide derivatives.[8] These molecules are known to be involved in cell signaling and inflammatory processes.
• Non-Enzymatic Oxidation (Autoxidation): As previously noted, the chemical structure of linoleic acid makes it highly susceptible to non-enzymatic, free-radical-mediated oxidation.[14] When linoleic acid levels are highly elevated, particularly in a state of systemic oxidative stress, this process can lead to the formation of a diverse group of oxidized linoleic acid metabolites (OXLAMs).[15] These OXLAMs, which include cytotoxic aldehydes like 4-hydroxynonenal (HNE), are strongly implicated as mediators of cellular damage and are associated with the pathogenesis of numerous chronic diseases, including cardiovascular disease, cancer, and neurodegenerative disorders.[15] The saturation of the primary desaturation/elongation pathway directly contributes to the shunting of excess linoleic acid into these oxidative pathways, providing a clear mechanism for how a nutritional excess can transform into a pathological trigger.

Molecular Pharmacology and Mechanism of Action

The pharmacological influence of linoleic acid is predominantly indirect, exerted through the vast and potent array of signaling molecules derived from its metabolism. It acts less like a classical drug with a single target and more like a "pro-nutrient" or "pro-drug" whose ultimate effect is determined by the complex enzymatic machinery of the cell. This machinery, in turn, is heavily influenced by genetic factors, overall health status, and, critically, the dietary balance of other fatty acids.

Precursor to Eicosanoids and Endocannabinoids

The most significant mechanism of action for linoleic acid is its role as the ultimate precursor to arachidonic acid (AA), the substrate for a class of powerful, short-lived signaling molecules known as eicosanoids.[8]

• Pro-inflammatory Mediators: Once released from cell membranes, AA is metabolized by two major enzymatic pathways. Cyclooxygenase (COX) enzymes convert AA into series-2 prostaglandins (e.g., PGE2) and thromboxanes (e.g., TXA2). Lipoxygenase (LOX) enzymes convert AA into series-4 leukotrienes (e.g., LTB4).[8] These molecules are potent mediators of inflammation, pain, fever, blood clotting, and smooth muscle contraction. While essential for acute responses to injury and infection, their chronic overproduction is a hallmark of many inflammatory diseases.[17]
• Endocannabinoids: Arachidonic acid is also the direct precursor for the synthesis of arachidonoylethanolamine, more commonly known as anandamide (AEA), a primary endogenous cannabinoid neurotransmitter.[8] Furthermore, linoleic acid itself can be converted to linoleoyl-ethanol-amide. This metabolite acts as an inhibitor of fatty acid amide hydrolase (FAAH), the enzyme responsible for degrading anandamide.[8] By inhibiting anandamide breakdown, linoleic acid metabolites can indirectly enhance endocannabinoid signaling, a system deeply involved in regulating appetite, pain, mood, and memory.

Regulation of Gene Expression via Nuclear Receptors

Linoleic acid and its metabolites can function as direct signaling molecules by binding to and activating nuclear receptors, which are transcription factors that regulate gene expression. This provides a direct link between dietary fat intake and the genetic programming of the cell.

• Peroxisome Proliferator-Activated Receptors (PPARs): Linoleic acid is an agonist for PPARs, particularly PPAR-γ.[21] PPARs are considered master regulators of lipid and glucose metabolism, adipocyte differentiation, and inflammatory responses.[23] Activation of PPARs by fatty acids is a key mechanism by which cells sense and adapt to changes in nutrient availability.
• Hepatocyte Nuclear Factor-4-α (HNF4A): Linoleic acid also acts as a full agonist for HNF4A, another critical transcription factor involved in the regulation of metabolism in the liver and pancreas.[21]

This ability to directly modulate gene expression demonstrates that dietary fats are not merely sources of energy but are powerful informational molecules that instruct cells to alter their metabolic and inflammatory states.

Interaction with Other Receptors and Proteins

In addition to its role as a precursor and a ligand for nuclear receptors, linoleic acid interacts with a variety of other cellular targets.

• Free Fatty Acid Receptors (FFARs): Linoleic acid is a full agonist at FFAR1 (also known as GPR40) and FFAR4 (GPR120).[21] These are G-protein coupled receptors expressed on the surface of various cells, including pancreatic beta-cells and immune cells. FFAR1 is involved in potentiating glucose-stimulated insulin secretion, while FFAR4 is recognized for mediating anti-inflammatory and insulin-sensitizing effects.
• Ion Channels: It exhibits complex modulatory effects on ion channels, which are critical for nerve and muscle function. It has been shown to act as both an activator and a channel blocker of voltage-gated potassium channels (Kv2.1) and as a blocker of the cold-sensing channel TRPM8.[21]
• Fatty Acid-Binding Proteins (FABPs): Inside the cell, the transport and availability of linoleic acid are managed by a family of fatty acid-binding proteins. Linoleic acid is an inhibitor of adipocyte FABP and binds with varying affinities to other FABP isoforms.[21] This binding influences its trafficking to different organelles for metabolism, storage, or signaling.

The existence of these multiple targets creates a complex signaling network. For instance, the ability of linoleic acid to serve as a precursor for pro-inflammatory eicosanoids (via AA) while also acting as an agonist at potentially anti-inflammatory receptors like FFAR4 and PPARs suggests a system with built-in homeostatic feedback loops. At low, physiological concentrations, these pathways may remain in balance. However, the immense substrate pressure from the high linoleic acid content of modern diets can overwhelm these regulatory mechanisms, leading to a pathological state where the pro-inflammatory arm of its metabolism dominates.

Pharmacodynamic Effects and the Omega-6/Omega-3 Paradigm

The pharmacodynamic effects of linoleic acid—what it does to the body—are defined by a stark duality: its absolute necessity at low levels versus its potential for harm at the high levels consumed in modern societies. This duality is best understood not by examining linoleic acid in isolation, but by viewing it through the lens of its interaction with omega-3 fatty acids.

Essentiality and Deficiency

Linoleic acid is classified as an essential fatty acid because humans lack the desaturase enzymes required to introduce a double bond beyond the ninth carbon of a fatty acid chain. Therefore, it cannot be synthesized de novo and must be obtained from the diet.[4]

The primary, unequivocal role of linoleic acid is structural. It is an indispensable component of a specific class of lipids called ceramides within the epidermis.[17] These linoleate-containing ceramides are critical for forming and maintaining the integrity of the skin's permeability barrier, which prevents excessive transepidermal water loss.[23] Consequently, a deficiency of linoleic acid manifests as scaly skin lesions (dermatitis), growth retardation, and increased susceptibility to infection.[17]

The amount of linoleic acid required to prevent these signs of deficiency is remarkably low, estimated to be between 1% and 2% of total daily caloric intake.[17] In the context of the modern food environment, where linoleic acid is ubiquitous, the risk of deficiency is practically non-existent for the vast majority of the population.[25] The public health concern has thus shifted entirely from preventing deficiency to mitigating the consequences of profound excess. The continued use of the term "essential fatty acid" in public messaging, while technically correct, may be contextually misleading, as it can inadvertently imply a need to actively seek out a nutrient that is already being overconsumed.

The Pro-Inflammatory and Anti-Inflammatory Balance: The Central Role of the Omega-6/Omega-3 Ratio

The most critical concept for understanding the pharmacodynamics of linoleic acid is that its effects are context-dependent, governed primarily by the dietary ratio of omega-6 to omega-3 fatty acids. This ratio functions as a metabolic switch that dictates the net inflammatory tone of the body.

• The Competing Pathways Model: The omega-6 family (parent: linoleic acid) and the omega-3 family (parent: alpha-linolenic acid, ALA) are metabolized by the same set of desaturase (FADS1, FADS2) and elongase enzymes. They are in direct competition for these enzymes' active sites.[26]
• Omega-6 Products: As detailed previously, the linoleic acid pathway leads primarily to arachidonic acid (AA), the precursor for potent pro-inflammatory mediators like series-2 prostaglandins and series-4 leukotrienes.[27]
• Omega-3 Products: The alpha-linolenic acid pathway leads to the long-chain omega-3s, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These are precursors to anti-inflammatory mediators, including series-3 prostaglandins and series-5 leukotrienes, as well as specialized pro-resolving mediators like resolvins and protectins.[28]
• The Ratio Determines the Outcome: The balance of pro-inflammatory versus anti-inflammatory eicosanoids produced by the body is therefore a direct function of the relative availability of omega-6 and omega-3 substrates. A high omega-6 to omega-3 ratio will saturate the enzymatic machinery with omega-6s, leading to a dominant pro-inflammatory output.[29]
• A Dramatic Dietary Shift: It is estimated that human beings evolved on a diet where the omega-6/omega-3 ratio was between 1:1 and 4:1. In stark contrast, the modern Western diet, rich in processed seed oils and low in fatty fish, exhibits a ratio of approximately 15:1 to 20:1.[27] This profound imbalance creates a biochemical environment that is chronically biased toward inflammation.
• Clinical Significance: A lower omega-6/omega-3 ratio is strongly associated with better health outcomes. Clinical and epidemiological studies have shown that ratios in the range of 2.5:1 to 5:1 are associated with reduced total mortality, decreased cancer cell proliferation in colorectal cancer patients, and suppression of inflammation in patients with rheumatoid arthritis.[29]

This competitive dynamic means that a high omega-6 intake does more than just add pro-inflammatory potential; it actively suppresses the body's ability to produce its own anti-inflammatory compounds by outcompeting the available omega-3s for the necessary enzymes. This highlights why strategies to improve inflammatory balance may be more effective when they combine an increase in omega-3 intake with a simultaneous reduction in omega-6 intake.

Impact on Lipid Profiles and Metabolic Health

Linoleic acid's effects on metabolic health are complex and at the center of ongoing debate. When it replaces saturated fats in the diet, linoleic acid intake is consistently associated with reductions in blood levels of total cholesterol and low-density lipoprotein (LDL) cholesterol.[8] For decades, this effect was considered the primary mechanism for its presumed cardiovascular benefit. However, as will be discussed, this biochemical improvement does not reliably translate into reduced cardiovascular mortality.[20]

Conversely, a high intake of linoleic acid, particularly in the context of the high omega-6/omega-3 ratio typical of Western diets, is linked to the pathogenesis of metabolic syndrome. The proposed mechanisms include the overproduction of pro-inflammatory eicosanoids and hyperactivity of the endocannabinoid system, which can promote central obesity and insulin resistance.[26] Adding to the complexity, some recent large-scale observational studies have reported a contradictory finding: higher levels of linoleic acid in blood plasma were associated with

lower levels of glucose, insulin, and biomarkers of insulin resistance.[32] This discrepancy represents a major point of controversy in nutritional science.

Clinical Evidence and Therapeutic Applications

The clinical relevance of linoleic acid spans its use in medical nutrition, its topical application in dermatology, and its highly controversial role in cardiovascular disease prevention. Additionally, its isomers, known as conjugated linoleic acids (CLA), are widely marketed as dietary supplements with a distinct set of applications and evidence.

Role in Clinical Nutrition

As an essential nutrient, linoleic acid is a standard and necessary component of medical nutritional formulations.

• Parenteral Nutrition: In patients who cannot consume food orally, lipid emulsions containing linoleic acid are administered intravenously as part of total parenteral nutrition (TPN). These emulsions provide a dense source of calories and prevent essential fatty acid deficiency, which is crucial in the management of undernutrition and malnutrition.[17] A completed Phase 4 clinical trial (NCT00530738) evaluated the safety and efficacy of long-term TPN with lipid emulsions containing linoleic acid, soybean oil, and medium-chain triglycerides for undernutrition.[36]
• Infant Nutrition: Linoleic acid is essential for normal growth and development, particularly of the skin and nervous system. It is therefore a required ingredient in infant formulas.[17] It is also a component of lipid emulsions used for parenteral nutrition in preterm infants.[37] However, the balance of fatty acids is critical, as infants have immature desaturase enzyme activity, making them more reliant on pre-formed long-chain PUFAs.[19]

Dermatological Applications

Given its fundamental role in maintaining the skin's barrier function, linoleic acid has direct applications in dermatology.

• Topical Repair and Treatment: Topical application of oils rich in linoleic acid has been shown in cell and animal models to repair a compromised skin barrier, reduce transepidermal water loss, promote wound healing, and exert anti-inflammatory effects.[23]
• Mechanism in Skin: Its primary mechanism is its incorporation into acylceramides, which are vital lipids for the structural integrity of the stratum corneum.[23] Additionally, linoleic acid can act as a ligand for PPARs in keratinocytes, activating pathways that regulate cell differentiation and barrier homeostasis.[23] It may also stimulate lipogenesis in sebocytes, contributing to the protective lipid layer on the skin's surface.[23]

The Cardiovascular Disease Controversy: A Critical Review

The role of linoleic acid in cardiovascular disease (CVD) is one of the most contentious topics in modern nutrition. Decades of dietary guidelines have advocated for replacing saturated fats with polyunsaturated fats, primarily linoleic acid, based on the rationale that this lowers LDL cholesterol. However, direct evidence from randomized controlled trials (RCTs) has produced conflicting and concerning results.

• Evidence of Harm from RCTs: The most striking evidence comes from the recovered data of the Sydney Diet Heart Study (SDHS), an RCT conducted from 1966-1973.[20] In this trial, men who had recovered from a myocardial infarction were randomized to a control group or an intervention group that replaced dietary saturated fats with safflower oil, a concentrated source of linoleic acid. The results showed that the intervention group had significantly higher rates of death from all causes, cardiovascular disease, and coronary heart disease.[20] An updated meta-analysis that included the SDHS data and other trials that selectively increased linoleic acid showed non-significant trends toward increased risk of death from coronary heart disease and cardiovascular disease, and no evidence of cardiovascular benefit.[20] The proposed mechanism for this harm is that in the context of oxidative stress, excessive dietary linoleic acid is readily oxidized to OXLAMs, which are pro-atherogenic.[20]
• Evidence of Benefit from Observational Studies: In stark contrast, many recent, large-scale prospective observational studies have found that higher dietary intake and higher plasma levels of linoleic acid are associated with a lower risk of CVD and type 2 diabetes.[32] These studies also report that higher linoleic acid is associated with lower levels of inflammatory biomarkers, glucose, and insulin.[32]

Table 6.1: Summary of Key Clinical Trials and Studies on Linoleic Acid and Cardiovascular Disease

Study Name/Type	Design	Population	Intervention/Exposure	Key Outcomes	Source(s)
Sydney Diet Heart Study (SDHS)	Randomized Controlled Trial (RCT)	Men (30-59 yrs) with prior coronary event	Replaced saturated fat with safflower oil (high LA)	Increased risk of all-cause, CVD, and CHD mortality in intervention group.	20
Updated Meta-analysis (including SDHS)	Meta-analysis of RCTs	Varies (primary & secondary prevention)	Selectively increased dietary LA	No evidence of cardiovascular benefit; non-significant trend toward increased risk of CHD and CVD death.	20
Recent Observational Studies	Prospective Cohort / Cross-sectional	General population / specific cohorts	Higher plasma levels of LA (biomarker of intake)	Lower risk of T2D and CVD events; lower levels of inflammatory markers, glucose, and insulin.	32

The apparent contradiction between these lines of evidence may be reconciled by considering the dietary context. The intervention in the SDHS involved providing a highly refined, isolated nutrient (safflower oil) devoid of the protective compounds found in whole foods. In contrast, higher plasma linoleic acid in modern observational cohorts may not reflect high processed oil intake, but rather serve as a biomarker for a dietary pattern rich in whole plant foods like nuts and seeds. These whole foods provide linoleic acid within a matrix of fiber, vitamins, minerals, and, critically, antioxidants (like vitamin E), which would protect the unstable fatty acid from oxidation. Therefore, the conflicting results may not be about linoleic acid per se, but about the profound difference between consuming it as part of a whole food versus as a refined, pro-oxidant industrial oil.

Conjugated Linoleic Acid (CLA): Isomers and Applications

Conjugated linoleic acid (CLA) is a family of positional and geometric isomers of linoleic acid, in which the double bonds are conjugated (i.e., separated by only one single bond). The most abundant and biologically active isomers are cis-9, trans-11 (c9,t11) and trans-10, cis-12 (t10,c12).[39] Unlike linoleic acid, which is found primarily in plants, CLA is produced naturally by microbes in the gastrointestinal tract of ruminant animals and is therefore found in grass-fed meat and dairy products.[19]

CLA is widely marketed as a dietary supplement, typically derived from chemically altered safflower oil, with claims for numerous health benefits.[39] However, the clinical evidence is mixed and often fails to replicate the benefits observed in animal studies.

• Obesity and Body Composition: This is the most common application for CLA supplements. Some human studies suggest that CLA can cause a modest reduction in body fat mass.[43] The proposed mechanism involves the modulation of PPARs to reduce fat deposition and increase energy expenditure.[45] However, the effects are generally small, unreliable, and do not lead to significant changes in overall body weight or BMI.[43]
• Hypertension: CLA taken in conjunction with the ACE inhibitor ramipril appeared to lower blood pressure more than ramipril alone. However, CLA by itself was not effective.[43]
• Other Conditions: Evidence for the use of CLA in preventing the common cold, managing diabetes, or improving hyperlipidemia is largely negative or insufficient.[43]

The study of CLA supplements serves as a case study in nutritional reductionism. While observational studies have linked higher consumption of CLA-containing foods (like grass-fed dairy) to better metabolic health, the isolated, high-dose supplements have produced inconsistent results and a profile of potential adverse effects.[47] This suggests that the benefits observed from the whole food source are likely attributable to the entire matrix of nutrients, not just the isolated CLA isomers.

Nutritional Science: Dietary Sources and Recommendations

Understanding the dietary sources of linoleic acid is fundamental to managing its intake and achieving a healthier fatty acid balance. The 20th century witnessed a dramatic and unprecedented shift in the human diet, leading to the current state of massive linoleic acid overconsumption.

Primary Dietary Sources

Linoleic acid is the most abundant polyunsaturated fatty acid in the Western diet.[17] Its sources can be broadly categorized into processed oils and whole foods.

• Industrial Seed and Vegetable Oils: These are the most concentrated sources of linoleic acid. The rise of these oils in the food supply is the single largest contributor to increased linoleic acid intake. Key examples include safflower oil, grapeseed oil, sunflower oil, corn oil, and soybean oil.[4] Soybean oil alone is estimated to account for approximately 45% of all dietary linoleic acid in the standard American diet.[42]
• Nuts and Seeds: Whole food sources are also rich in linoleic acid. These include walnuts, sunflower seeds, pine nuts, pecans, Brazil nuts, and pumpkin seeds.[4]
• Other Sources: Tofu (made from soybeans) and peanut butter are significant plant-based sources.[51] Animal products, including meat, poultry, eggs, and dairy, also contain linoleic acid. The content in these products is highly dependent on the animal's diet; animals raised on grain-based feeds (rich in corn and soy) have much higher levels of linoleic acid in their tissues and products compared to those that are grass-fed.[27] Similarly, farmed salmon, often fed vegetable oil-based pellets, has a significantly higher linoleic acid content than wild-caught salmon.[25]

Table 7.1: Linoleic Acid Content of Common Foods and Oils

Food/Oil	Serving Size	Linoleic Acid Content (g)	Source(s)
Oils
Safflower Oil	1 tablespoon	10.0	42
Sunflower Oil	1 tablespoon	8.9	42
Corn Oil	1 tablespoon	7.3	42
Soybean Oil	1 tablespoon	8.9	42
Avocado Oil	1 tablespoon	1.75	52
Nuts & Seeds
Walnuts	1 ounce (28g)	10.8	52
Sunflower Seeds	1 ounce (28g)	10.6	52
Hemp Seeds	3 tablespoons (30g)	8.24	52
Pine Nuts	1 ounce	9.4	42
Pecans	1 ounce	6.4	42
Other Foods
Tofu	1/4 block (122g)	6.06	52
Peanut Butter	1 tablespoon (16g)	1.96	52

Historical vs. Modern Consumption

The current high intake of linoleic acid is a very recent phenomenon in human history.

• Ancestral Intake: For most of human evolution, diets provided linoleic acid at levels of approximately 2-3% of total daily calories.[53]
• Modern Intake: The average intake in modern Western societies has skyrocketed to 6-10% of total calories, with some estimates being even higher.[16] This dramatic increase of more than 1,000-fold is primarily due to the replacement of traditional animal fats (like butter and lard) with industrial seed oils in processed foods, restaurants, and home cooking, a shift that began in the early 20th century.[25]

Dietary Guidelines and Recommended Intake

Official dietary guidelines reflect the dual nature of linoleic acid as both an essential nutrient and a potential risk factor when consumed in excess.

• Adequate Intake (AI): To prevent deficiency, national health bodies have established AI levels. For adults (19-50 years), the AI is 13 g/day for men and 8 g/day for women. These values are adjusted for different life stages, including infancy, childhood, pregnancy, and lactation.[17]
• Recommendations for Chronic Disease Prevention: The American Heart Association recommends that 5-10% of total energy intake should come from omega-6 PUFAs (of which linoleic acid is the vast majority) to reduce the risk of coronary heart disease, based on its cholesterol-lowering effects.[17]
• The Omega-6/Omega-3 Ratio: There is a growing consensus that the ratio of omega-6 to omega-3 fatty acids is a more important metric for health than the absolute intake of omega-6s alone. Various authorities have recommended dietary ratios ranging from 5:1 to 10:1.[54] However, a large body of evidence suggests that lower ratios, closer to the ancestral norm of 4:1 or less, are optimal for reducing the risk of a wide range of chronic inflammatory diseases.[29]

Safety, Toxicology, and Drug Interactions

The safety profile of linoleic acid varies significantly depending on its form, dose, and context of use. As a pure chemical or a standard dietary component, it is relatively benign. However, as a high-dose, isolated supplement (particularly in its conjugated forms), it carries a distinct profile of metabolic risks.

General Safety Profile and Toxicology

According to standard chemical safety data, pure linoleic acid is considered to have a low order of acute toxicity.

• Irritation: It is classified as a mild irritant. Exposure to the neat compound may cause mild irritation of the eyes, skin, and mucous membranes or respiratory tract.[13]
• Systemic Toxicity: Under the Globally Harmonized System (GHS) of classification, it is not classified as acutely toxic, corrosive, a skin or respiratory sensitizer, mutagenic, carcinogenic, or a reproductive toxicant.[56]
• Handling and Stability: Due to its susceptibility to oxidation, it should be stored under an inert atmosphere (e.g., nitrogen), refrigerated, and protected from light and air.[12] It is combustible but has a high flash point and does not present an unusual fire hazard.[13] It is chemically incompatible with strong oxidizing agents, with which it may react vigorously.[13]

This profile of a relatively benign chemical irritant stands in stark contrast to the systemic metabolic risks associated with high-dose supplementation, underscoring the principle that isolating a nutrient from its food matrix and consuming it at pharmacological doses fundamentally alters its biological effects and safety considerations.

Adverse Effects of Supplementation (Primarily CLA)

While linoleic acid from whole foods is generally regarded as safe, high-dose supplementation with its isomers, conjugated linoleic acid (CLA), is associated with a range of adverse effects.

• Common Side Effects: The most frequently reported side effects are gastrointestinal in nature, including stomach upset, nausea, diarrhea, and indigestion.[43] Fatigue and headache have also been documented.[43]
• Serious Metabolic Concerns: More concerning are the potential metabolic derangements associated with high-dose or long-term CLA supplementation. Studies in humans and animals have shown that supplemental CLA can:
• Induce or Worsen Insulin Resistance: This is a significant concern, particularly for individuals who are obese or have metabolic syndrome or type 2 diabetes.[19]
• Promote Fat Accumulation in the Liver (Hepatic Steatosis): This is a stepping stone toward more serious liver disease and is a feature of metabolic syndrome.[19]
• Drive Inflammation and Oxidative Stress: Despite claims of being anti-inflammatory, some human studies show that supplemental CLA can increase markers of inflammation.[47]
• Negatively Impact Blood Lipids: CLA has been shown to lower levels of "good" high-density lipoprotein (HDL) cholesterol.[47]

Known Drug Interactions

The potential for linoleic acid and its isomers to interact with medications primarily relates to their effects on blood clotting and blood pressure.

• Anticoagulant/Antiplatelet Drugs: CLA may slow blood clotting. Concomitant use with medications that also have this effect (e.g., warfarin, clopidogrel, aspirin, NSAIDs) could theoretically increase the risk of bruising and bleeding.[43] It is recommended to discontinue CLA supplements at least two weeks before scheduled surgery to mitigate this risk.[43]
• Antihypertensive Drugs: CLA may have a blood pressure-lowering effect. When taken with antihypertensive medications (e.g., ACE inhibitors like ramipril, beta-blockers, diuretics), there is a potential for an additive effect that could lead to hypotension (blood pressure that is too low).[43]
• Drug Absorption: As a lipid-based supplement, CLA may alter the absorption of other orally administered medications, potentially diminishing or potentiating their effects. This is a general consideration for any fat-based supplement taken with other drugs.[60]

Synthesis and Future Directions

Linoleic acid is a biochemically and nutritionally complex molecule, embodying a classic "dose makes the poison" principle. It is a Janus-faced nutrient: absolutely essential for human life at low levels, yet implicated in the pathophysiology of numerous chronic diseases when consumed at the excessive levels characteristic of the modern, industrialized food system. A comprehensive review of the evidence reveals that its biological impact cannot be understood in isolation but is instead governed by a series of critical contextual factors.

The central thesis of this analysis is that the effect of linoleic acid is dictated by context. The most important of these factors is the background dietary omega-6 to omega-3 ratio, which acts as a master switch controlling the body's net inflammatory state. The modern dietary imbalance, heavily skewed toward omega-6 fatty acids, saturates shared metabolic pathways, promoting the synthesis of pro-inflammatory eicosanoids while actively suppressing the production of anti-inflammatory mediators from omega-3s. Other crucial contextual factors include the dietary source of the linoleic acid (as part of a whole food matrix versus as a refined industrial oil), the presence of protective antioxidants in the diet, and the underlying genetic and metabolic health of the individual.

The long-standing and simplistic dietary advice to broadly "replace saturated fats with polyunsaturated fats" is now obsolete and potentially harmful. The evidence from the Sydney Diet Heart Study suggests that replacing saturated fat with a concentrated source of omega-6 linoleic acid, in the absence of sufficient omega-3s, does not confer a cardiovascular benefit and may increase mortality risk. Conversely, the apparent benefits seen in recent observational studies are likely a reflection of dietary patterns rich in whole foods, not a vindication of high-dose refined seed oil consumption.

This nuanced understanding necessitates a paradigm shift in both public health recommendations and future scientific inquiry.

• Future Dietary Guidelines: Recommendations must evolve beyond a simple focus on macronutrient categories (e.g., "PUFAs") and instead emphasize the importance of restoring a healthier omega-6 to omega-3 balance. This translates to practical advice that encourages the consumption of whole-food sources of fats (nuts, seeds, avocados) and omega-3-rich seafood, while actively reducing the intake of processed foods made with high-linoleic acid industrial seed oils (soybean, corn, sunflower, safflower).
• Future Research Directions: Key knowledge gaps remain. There is a critical need for long-term, well-controlled randomized clinical trials to definitively resolve the cardiovascular controversy. Such trials should not test high-linoleic acid oils in isolation but should instead compare dietary patterns that achieve a balanced omega-6/omega-3 ratio (e.g., a Mediterranean-style diet) against a standard Western diet. Furthermore, research is needed to better understand the long-term impact of high linoleic acid intake on the human endocannabinoid system, the generation of OXLAMs in vivo, and the progression of chronic inflammatory and metabolic diseases. Elucidating the interplay between dietary fatty acid patterns and genetic variations in fatty acid metabolism (e.g., in FADS genes) will also be crucial for developing more personalized nutritional strategies.

Works cited

1. Linoleic Acid | C18H32O2 | CID 5280450 - PubChem, accessed September 2, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Linoleic-Acid
2. Linoleic acid | C18H32O2 - ChemSpider, accessed September 2, 2025, https://www.chemspider.com/Chemical-Structure.4444105.html
3. Linoleic Acid-Omega 6 Fatty Acid Chemical Structure Molecular Model from Indigo, accessed September 2, 2025, https://www.indigoinstruments.com/molecular_models/orbit/kits/linoleic-acid-structure-molecule-model-68811w.html
4. Linoleic Acid - Cayman Chemical, accessed September 2, 2025, https://www.caymanchem.com/product/90150/linoleic-acid
5. CAS Number 60-33-3 | Linoleic Acid - Spectrum Chemical, accessed September 2, 2025, https://www.spectrumchemical.com/cas/60-33-3
6. Linoleic Acid | CAS 60-33-3 | SCBT - Santa Cruz Biotechnology, accessed September 2, 2025, https://www.scbt.com/p/linoleic-acid-60-33-3
7. Linoleic acid | CAS Number 60-33-3 - LGC Standards, accessed September 2, 2025, https://www.lgcstandards.com/MQ/en/Linoleic-acid/p/DRE-CA14635400
8. Linoleic acid - Wikipedia, accessed September 2, 2025, https://en.wikipedia.org/wiki/Linoleic_acid
9. linoleic acid, 60-33-3 - The Good Scents Company, accessed September 2, 2025, https://www.thegoodscentscompany.com/data/rw1045901.html
10. CHEBI:17351 - linoleic acid - EMBL-EBI, accessed September 2, 2025, https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:17351
11. 3D structure for Linoleic acid (DB14104) | DrugBank Online, accessed September 2, 2025, https://go.drugbank.com/structures/small_molecule_drugs/DB14104
12. Linoleic Acid 60-33-3 | Tokyo Chemical Industry (India) Pvt. Ltd., accessed September 2, 2025, https://www.tcichemicals.com/IN/en/p/L0053
13. LINOLEIC ACID - CAMEO Chemicals - NOAA, accessed September 2, 2025, https://cameochemicals.noaa.gov/chemical/20571
14. Oxidation pathways of linoleic acid revisited with electrodynamic balance–mass spectrometry - RSC Publishing, accessed September 2, 2025, https://pubs.rsc.org/en/content/articlehtml/2023/ea/d2ea00127f
15. Linoleic Acid: A Narrative Review of the Effects of Increased Intake in the Standard American Diet and Associations with Chronic Disease - MDPI, accessed September 2, 2025, https://www.mdpi.com/2072-6643/15/14/3129
16. pmc.ncbi.nlm.nih.gov, accessed September 2, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10386285/
17. Linoleic Acid - PMC, accessed September 2, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3650500/
18. Linoleic acid (LA) metabolism - Reactome Pathway Database, accessed September 2, 2025, https://reactome.org/content/detail/R-HSA-2046105
19. What is Linoleic Acid? - News-Medical, accessed September 2, 2025, https://www.news-medical.net/health/What-is-Linoleic-Acid.aspx
20. Use of dietary linoleic acid for secondary prevention of coronary ..., accessed September 2, 2025, https://www.bmj.com/content/346/bmj.e8707
21. linoleic acid | Ligand page - IUPHAR/BPS Guide to PHARMACOLOGY, accessed September 2, 2025, https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=1052
22. Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation - Frontiers, accessed September 2, 2025, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.587140/full
23. The Role of Linoleic Acid in Skin and Hair Health: A Review - PMC, accessed September 2, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11719646/
24. Linoleic acid: Uses, Interactions, Mechanism of Action | DrugBank ..., accessed September 2, 2025, https://go.drugbank.com/drugs/DB14104
25. What Is Linoleic Acid? Facts, Health Effects, and How to Avoid It | Zero Acre Farms, accessed September 2, 2025, https://www.zeroacre.com/blog/linoleic-acid-facts
26. The Effects of a Low Linoleic Acid/α-Linolenic Acid Ratio on Lipid Metabolism and Endogenous Fatty Acid Distribution in Obese Mice - MDPI, accessed September 2, 2025, https://www.mdpi.com/1422-0067/24/15/12117
27. How to Optimize Your Omega-6 to Omega-3 Ratio - Healthline, accessed September 2, 2025, https://www.healthline.com/nutrition/optimize-omega-6-omega-3-ratio
28. Linolenic acid: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed September 2, 2025, https://go.drugbank.com/drugs/DB00132
29. Why an Optimal Omega-6 to 3 Ratio and Omega-3 Dose May Vary ..., accessed September 2, 2025, https://www.grassrootshealth.net/blog/optimal-omega-6-3-ratio-omega-3-dose-may-vary-based-individuals-current-health/
30. The importance of the ratio of omega-6/omega-3 essential fatty acids, accessed September 2, 2025, https://pubmed.ncbi.nlm.nih.gov/12442909/
31. Omega-3s vs. Omega-6s: Balancing the Scale for Optimal Health in Clinical Practice, accessed September 2, 2025, https://www.rupahealth.com/post/omega-3s-vs-omega-6s-balancing-the-scale-for-optimal-health-in-clinical-practice
32. Linoleic acid, a key component of seed oils, may actually be good for cardiac health. - Technology Networks, accessed September 2, 2025, https://www.technologynetworks.com/applied-sciences/news/more-evidence-that-seeds-oils-arent-bad-for-us-400434
33. Linoleic Acid: A Nutritional Quandary - MDPI, accessed September 2, 2025, https://www.mdpi.com/2227-9032/5/2/25
34. Exploration of the Mechanism of Linoleic Acid Metabolism Dysregulation in Metabolic Syndrome - PMC - PubMed Central, accessed September 2, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9722286/
35. Linoleic acid may help to lower risks for heart disease and type 2 ..., accessed September 2, 2025, https://www.news-medical.net/news/20250601/Linoleic-acid-may-help-to-lower-risks-for-heart-disease-and-type-2-diabetes.aspx
36. Undernutrition Completed Phase 4 Trials for Linoleic acid (DB14104) | DrugBank Online, accessed September 2, 2025, https://go.drugbank.com/indications/DBCOND0033590/clinical_trials/DB14104?phase=4&status=completed
37. Soybean oil Completed Phase 2 Trials for Preterm, Infant / Parenteral Nutrition n-3 Fatty Acids Prevention - DrugBank, accessed September 2, 2025, https://go.drugbank.com/drugs/DB09422/clinical_trials?conditions=DBCOND0037541%2CDBCOND0074747&phase=2&purpose=prevention&status=completed
38. pmc.ncbi.nlm.nih.gov, accessed September 2, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11719646/#:~:text=Studies%20based%20on%20animal%20or,the%20stimulation%20of%20hair%20growth.
39. Conjugated Linoleic Acid: A Fatty Acid With Health Benefits | VCE Publications | Virginia Tech, accessed September 2, 2025, https://www.pubs.ext.vt.edu/HNFE/hnfe-1123/hnfe-1123.html
40. CLA (Conjugated Linoleic Acid) 1000 mg - Pure Encapsulations, accessed September 2, 2025, https://www.pureencapsulationspro.com/cla-conjugated-linoleic-acid.html
41. Progress of Conjugated Linoleic Acid on Milk Fat Metabolism in Ruminants and Humans, accessed September 2, 2025, https://www.mdpi.com/2076-2615/13/21/3429
42. Linoleic Acid Can Help Improve Brain, Heart, Skin, Bone & Reproductive Health - Dr. Axe, accessed September 2, 2025, https://draxe.com/nutrition/linoleic-acid/
43. Conjugated Linoleic Acid (CLA) - Uses, Side Effects, and More, accessed September 2, 2025, https://www.webmd.com/vitamins/ai/ingredientmono-826/conjugated-linoleic-acid-cla
44. Conjugated Linoleic Acid benefits, dosage, and side effects - Examine.com, accessed September 2, 2025, https://examine.com/supplements/conjugated-linoleic-acid/
45. Antiobesity Mechanisms of Action of Conjugated Linoleic Acid - PMC, accessed September 2, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2826589/
46. DIETARY CONJUGATED LINOLEIC ACID IN HEALTH: Physiological Effects and Mechanisms of Action1 | Annual Reviews, accessed September 2, 2025, https://www.annualreviews.org/doi/10.1146/annurev.nutr.22.021302.121842
47. CLA (Conjugated Linoleic Acid): A Detailed Review - Healthline, accessed September 2, 2025, https://www.healthline.com/nutrition/conjugated-linoleic-acid
48. Conjugated Linoleic Acid (CLA) - WebMD, accessed September 2, 2025, https://www.webmd.com/vitamins-and-supplements/conjugated-linoleic-acid-cla
49. Conjugated Linoleic Acid | Memorial Sloan Kettering Cancer Center, accessed September 2, 2025, https://www.mskcc.org/cancer-care/integrative-medicine/herbs/conjugated-linoleic-acid
50. Oils Rich in Linoleic Acid - News-Medical, accessed September 2, 2025, https://www.news-medical.net/health/Oils-Rich-in-Linoleic-Acid.aspx
51. 6 Foods That Are High in Linoleic Acid | iwi life, accessed September 2, 2025, https://iwilife.com/blogs/news/foods-high-in-linoleic-acid-ala
52. 10 Omega-6 Foods to Add to Your Diet - Healthline, accessed September 2, 2025, https://www.healthline.com/nutrition/omega-6-foods
53. How Much Linoleic Acid Do You Need? - The Paleo Diet®, accessed September 2, 2025, https://thepaleodiet.com/how-much-linoleic-acid-do-you-need/
54. Total fat & fatty acids - Nutrient Reference Values - Eat For Health, accessed September 2, 2025, https://www.eatforhealth.gov.au/nutrient-reference-values/nutrients/fats-total-fat-fatty-acids
55. Safety Data Sheet - Cayman Chemical, accessed September 2, 2025, https://cdn.caymanchem.com/cdn/msds/10006834m.pdf
56. Safety Data Sheet: Linoleic acid - Carl ROTH, accessed September 2, 2025, https://www.carlroth.com/medias/SDB-5315-MT-EN.pdf?context=bWFzdGVyfHNlY3VyaXR5RGF0YXNoZWV0c3wyMzQ2NjR8YXBwbGljYXRpb24vcGRmfGFEZ3dMMmc1Tnk4NU1UYzFNalkxTURFM09EZzJMMU5FUWw4MU16RTFYMDFVWDBWT0xuQmtaZ3xkNWYyZjYxZDdhOGNhMTBhYzY2MzRhMDllYzQ2YmI0ZTE1ODhkY2EwZjQ5NTZiOTg4ODc5ODY3NGE5MDhkMzQ0
57. SAFETY DATA SHEET - Sigma-Aldrich, accessed September 2, 2025, https://www.sigmaaldrich.com/FR/en/sds/ALDRICH/62240
58. www.webmd.com, accessed September 2, 2025, https://www.webmd.com/vitamins/ai/ingredientmono-826/conjugated-linoleic-acid-cla#:~:text=It%20is%20possibly%20safe%20when,nausea%2C%20fatigue%2C%20and%20headache.
59. www.webmd.com, accessed September 2, 2025, https://www.webmd.com/vitamins/ai/ingredientmono-826/conjugated-linoleic-acid-cla#:~:text=Medications%20that%20slow%20blood%20clotting,risk%20of%20bruising%20and%20bleeding.
60. How CLA (Conjugated Linoleic Acid) Interacts with Weight Loss Medications | Curex, accessed September 2, 2025, https://getcurex.com/weight-loss-blog/how-cla-conjugated-linoleic-acid-interacts-with-weight-loss-medications